Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, DarioHealth Corp’s stock clocked out at $0.69, down -12.45% from its previous closing price of $0.79. In other words, the price has decreased by -$12.45 from its previous closing price. On the day, 16.54 million shares were traded. DRIO stock price reached its highest trading level at $1.38 during the session, while it also had its lowest trading level at $0.645.
Ratios:
To gain a deeper understanding of DRIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.57. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.36.
On April 22, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $31.
On March 23, 2021, Stifel started tracking the stock assigning a Buy rating and target price of $30.Stifel initiated its Buy rating on March 23, 2021, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Nelson Steven Charles bought 5,000 shares for $0.91 per share. The transaction valued at 4,546 led to the insider holds 55,000 shares of the business.
Nelson Steven Charles bought 5,000 shares of DRIO for $4,221 on Sep 10 ’24. The Chief Commercial Officer now owns 45,000 shares after completing the transaction at $0.84 per share. On Sep 11 ’24, another insider, Nelson Steven Charles, who serves as the Chief Commercial Officer of the company, bought 5,000 shares for $0.80 each. As a result, the insider paid 4,022 and bolstered with 50,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRIO now has a Market Capitalization of 23594708 and an Enterprise Value of 38533676. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.15 while its Price-to-Book (P/B) ratio in mrq is 0.37. Its current Enterprise Value per Revenue stands at 1.672 whereas that against EBITDA is -0.72.
Stock Price History:
The Beta on a monthly basis for DRIO is 1.41, which has changed by -0.61650485 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, DRIO has reached a high of $2.60, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -14.73%, while the 200-Day Moving Average is calculated to be -36.62%.
Shares Statistics:
It appears that DRIO traded 185.02K shares on average per day over the past three months and 565640 shares per day over the past ten days. A total of 31.32M shares are outstanding, with a floating share count of 28.62M. Insiders hold about 25.06% of the company’s shares, while institutions hold 21.01% stake in the company. Shares short for DRIO as of 1735603200 were 1957248 with a Short Ratio of 10.58, compared to 1732838400 on 1907621. Therefore, it implies a Short% of Shares Outstanding of 1957248 and a Short% of Float of 6.38.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1.0 analysts currently analyzing and rating the stock of DarioHealth Corp (DRIO).The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.82 and -$0.82 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$0.39, with 1.0 analysts recommending between -$0.39 and -$0.39.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $7.41M. It ranges from a high estimate of $7.42M to a low estimate of $7.4M. As of the current estimate, DarioHealth Corp’s year-ago sales were $3.62MFor the next quarter, 3 analysts are estimating revenue of $8.14M. There is a high estimate of $8.14M for the next quarter, whereas the lowest estimate is $8.14M.
A total of 3 analysts have provided revenue estimates for DRIO’s current fiscal year. The highest revenue estimate was $26.86M, while the lowest revenue estimate was $26.84M, resulting in an average revenue estimate of $26.85M. In the same quarter a year ago, actual revenue was $20.35MBased on 3 analysts’ estimates, the company’s revenue will be $37.41M in the next fiscal year. The high estimate is $39.19M and the low estimate is $34.74M.
